David Saltzberg, MD
Gastroenterology · Towson, MDNPI 1356443360
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 32.0% of the total. Reporting peaked in 2021 at $568 and has fallen 74.3% since, to $146 in 2025. That places this record below the midpoint for gastroenterology clinicians in MD, where the typical reported total is $2,763.
Across 109 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$602
- Johnson & Johnson$396
- Takeda Pharmaceuticals U.S.A., Inc.$307
- Pfizer$81
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$74
- Gilead$41
- plus $379 from 15 others
What the payments were for
- Food & beverage$1,880100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $602 |
| Johnson & Johnson | 23 | $396 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $307 |
| Pfizer | 5 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Gilead | 2 | $41 |
| Merck | 2 | $40 |
| Olympus America Inc. | 2 | $36 |
| Bristol Myers Squibb | 2 | $33 |
| Sanofi | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Boston Scientific | 2 | $29 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Ardelyx, Inc. | 1 | $27 |
| Acacia Pharma Inc | 1 | $26 |
| Evoke Pharma, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Medtronic | 1 | $12 |
| QOL Medical, LLC | 2 | $8 |
How this compares
$1,880 in reported general payments places this provider in the 40th percentile of 455 gastroenterology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Towson
- Apurva ModiRockville$1.1M
- Sergey KantsevoyBaltimore$1.1M
- Anurag MaheshwariBaltimore$803K
- Aline Charabaty PishvaianBaltimore$631K
- Zachary BormanChevy Chase$520K
- Mouen KhashabBaltimore$440K
- Erica CohenChevy Chase$385K
- Natarajan RavendhranCatonsville$367K
- Raymond CrossBaltimore$341K
- Raja TaunkAnnapolis$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.